AHA GUIDELINES Bundle (free trial)

Lower Extremity Peripheral Artery Disease 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521560

Contents of this Issue

Navigation

Page 16 of 55

17 Table 8. Alternative Diagnoses for Nonhealing Lower Extremity Wounds With Normal Physiological Testing (Not PAD Related) Condition Location Characteristics and Causes Autoimmune injury Toes, foot, leg • With blisters (eg, pemphigoid, pemphigus, epidermolysis bullosa) • Without blisters (eg, dermatomyositis, lupus, scleroderma) Infection Toes, foot, leg • Bacterial (eg, Pseudomonas, necrotizing Streptococcus) • Fungal (eg, blastomycosis, Madura foot, chromomycosis) • Mycobacterial • Parasitic (eg, Chagas, leishmaniasis) • Viral (eg, herpes) Inflammatory ulcer Toes, foot, leg • Necrobiosis lipoidica • Pyoderma gangrenosum • Granuloma annulare Local injury Toes, foot, leg • Trauma • Insect or animal bite • Burn Malignancy Toes, foot, leg • Primary skin malignancy • Metastatic malignancy • Malignant transformation of ulcer Medication- related ulcer Toes, foot, leg • Drug reactions (eg, erythema multiforme) • Medication direct toxicity (eg, doxorubicin, hydroxyurea, some tyrosine kinase inhibitors) Neuropathic ulcer Pressure zones of foot • Hyperkeratosis surrounds the ulcer • Diabetes with peripheral neuropathy • Peripheral neuropathy without diabetes • Leprosy Venous ulcer Distal leg, especially above medial malleolus • Develops in regions of skin changes due to chronic venous disease and local venous hypertension • Typically wet (ie, wound drainage) rather than dry lesion Modified with permission from Gerhard-Herman MD, et al. Copyright © 2017 American Heart Association, Inc., and American College of Cardiolog y Foundation.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Lower Extremity Peripheral Artery Disease 2024